HY-104077R Search Results


remdesivir  (MedChemExpress)
96
MedChemExpress remdesivir
Remdesivir, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/remdesivir/product/MedChemExpress
Average 96 stars, based on 1 article reviews
remdesivir - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
gs 441524  (MedChemExpress)
92
MedChemExpress gs 441524
Gs 441524, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gs 441524/product/MedChemExpress
Average 92 stars, based on 1 article reviews
gs 441524 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
compounds remdesivir  (Gilead Sciences)
97
Gilead Sciences compounds remdesivir
(A) Virus titer in supernatants from SARS-CoV-2 (VIC01) infected H9- derived WT and ACE2 KO cardiac and lung AT2 cells. (B) Virus titer at 3 dpi in supernatants from lung AT2 (H9) and cardiac cells (NKX2-5) treated with two α-ACE2 antibodies or a human IgG1 isotype control before infection with SARS-CoV-2. (C) Virus titer at 3 dpi in supernatant from cardiac cells (red triangles) and lung AT2 cells (blue squares) infected with SARS-CoV-2 (VIC01) in the presence of Camostat, CA-074 or DMSO (vehicle control). Virus titres and genome copies at 3 dpi in supernatant from Vero, lung AT2 and cardiac cells infected with SARS-CoV-2 VIC01 in the presence of various concentrations of <t>Remdesivir</t> (D) or NHC (E).
Compounds Remdesivir, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compounds remdesivir/product/Gilead Sciences
Average 97 stars, based on 1 article reviews
compounds remdesivir - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

Image Search Results


(A) Virus titer in supernatants from SARS-CoV-2 (VIC01) infected H9- derived WT and ACE2 KO cardiac and lung AT2 cells. (B) Virus titer at 3 dpi in supernatants from lung AT2 (H9) and cardiac cells (NKX2-5) treated with two α-ACE2 antibodies or a human IgG1 isotype control before infection with SARS-CoV-2. (C) Virus titer at 3 dpi in supernatant from cardiac cells (red triangles) and lung AT2 cells (blue squares) infected with SARS-CoV-2 (VIC01) in the presence of Camostat, CA-074 or DMSO (vehicle control). Virus titres and genome copies at 3 dpi in supernatant from Vero, lung AT2 and cardiac cells infected with SARS-CoV-2 VIC01 in the presence of various concentrations of Remdesivir (D) or NHC (E).

Journal: bioRxiv

Article Title: Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2

doi: 10.1101/2022.09.20.508614

Figure Lengend Snippet: (A) Virus titer in supernatants from SARS-CoV-2 (VIC01) infected H9- derived WT and ACE2 KO cardiac and lung AT2 cells. (B) Virus titer at 3 dpi in supernatants from lung AT2 (H9) and cardiac cells (NKX2-5) treated with two α-ACE2 antibodies or a human IgG1 isotype control before infection with SARS-CoV-2. (C) Virus titer at 3 dpi in supernatant from cardiac cells (red triangles) and lung AT2 cells (blue squares) infected with SARS-CoV-2 (VIC01) in the presence of Camostat, CA-074 or DMSO (vehicle control). Virus titres and genome copies at 3 dpi in supernatant from Vero, lung AT2 and cardiac cells infected with SARS-CoV-2 VIC01 in the presence of various concentrations of Remdesivir (D) or NHC (E).

Article Snippet: Compounds remdesivir (MedChemExpress, Cat. HY104077), NHC (β- D-N4-hydroxycytidine, MedChemExpress, Cat. HY125033), favipiravir (Toyama Chemicals Co. Ltd, Japan, T705), tizoxanide (Romark Laboratories, Tampa, FL) chloroquine (Sigma Aldrich, Cat. C6628) and piperaquine (Sigma Aldrich, Cat. C7874) were tested in lung AT2, cardiac and Vero cells in 24 well tissue culture plates.

Techniques: Infection, Derivative Assay

(A) Cell viability in uninfected Vero, lung AT2 and cardiac cells following 3 days culture in the presence of Remdesivir or NHC at the indicated concentrations. (B) Virus titer and viral genome copies in the supernatant at 3 dpi in Vero, lung AT2, NKX2- 5 cardiac and ALP3K KO cells infected with SARS-CoV-2 in the presence of 1µM or 10µM Favipiravir, Chloroquine, Tizoxanide or Piperaquine. Cell viability of uninfected cells after 3 days culture in the presence of the above drugs.

Journal: bioRxiv

Article Title: Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2

doi: 10.1101/2022.09.20.508614

Figure Lengend Snippet: (A) Cell viability in uninfected Vero, lung AT2 and cardiac cells following 3 days culture in the presence of Remdesivir or NHC at the indicated concentrations. (B) Virus titer and viral genome copies in the supernatant at 3 dpi in Vero, lung AT2, NKX2- 5 cardiac and ALP3K KO cells infected with SARS-CoV-2 in the presence of 1µM or 10µM Favipiravir, Chloroquine, Tizoxanide or Piperaquine. Cell viability of uninfected cells after 3 days culture in the presence of the above drugs.

Article Snippet: Compounds remdesivir (MedChemExpress, Cat. HY104077), NHC (β- D-N4-hydroxycytidine, MedChemExpress, Cat. HY125033), favipiravir (Toyama Chemicals Co. Ltd, Japan, T705), tizoxanide (Romark Laboratories, Tampa, FL) chloroquine (Sigma Aldrich, Cat. C6628) and piperaquine (Sigma Aldrich, Cat. C7874) were tested in lung AT2, cardiac and Vero cells in 24 well tissue culture plates.

Techniques: Infection